239 related articles for article (PubMed ID: 14557439)
21. Androstane-3alpha,17beta-diol glucuronide as a steroid correlate of visceral obesity in men.
Tchernof A; Labrie F; Bélanger A; Prud'homme D; Bouchard C; Tremblay A; Nadeau A; Després JP
J Clin Endocrinol Metab; 1997 May; 82(5):1528-34. PubMed ID: 9141545
[TBL] [Abstract][Full Text] [Related]
22. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
[TBL] [Abstract][Full Text] [Related]
23. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease.
Couillard C; Mauriège P; Prud'homme D; Nadeau A; Tremblay A; Bouchard C; Després JP
Diabetologia; 1997 Oct; 40(10):1178-84. PubMed ID: 9349599
[TBL] [Abstract][Full Text] [Related]
24. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.
Cartier A; Lemieux I; Alméras N; Tremblay A; Bergeron J; Després JP
J Clin Endocrinol Metab; 2008 May; 93(5):1931-8. PubMed ID: 18319319
[TBL] [Abstract][Full Text] [Related]
25. Predominant role of obesity/insulin resistance in oxidative stress development.
D'Archivio M; Annuzzi G; Varì R; Filesi C; Giacco R; Scazzocchio B; Santangelo C; Giovannini C; Rivellese AA; Masella R
Eur J Clin Invest; 2012 Jan; 42(1):70-8. PubMed ID: 21679180
[TBL] [Abstract][Full Text] [Related]
26. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
27. Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men.
Asferg CL; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
Diabet Med; 2014 Jun; 31(6):728-32. PubMed ID: 24533694
[TBL] [Abstract][Full Text] [Related]
28. Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance.
Arner P; Stenson BM; Dungner E; Näslund E; Hoffstedt J; Ryden M; Dahlman I
J Clin Endocrinol Metab; 2008 Jun; 93(6):2249-54. PubMed ID: 18381574
[TBL] [Abstract][Full Text] [Related]
29. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance.
Selva DM; Lecube A; Hernández C; Baena JA; Fort JM; Simó R
J Clin Endocrinol Metab; 2009 Nov; 94(11):4499-507. PubMed ID: 19622624
[TBL] [Abstract][Full Text] [Related]
30. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.
Montuschi P; Ciabattoni G; Paredi P; Pantelidis P; du Bois RM; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1524-7. PubMed ID: 9817703
[TBL] [Abstract][Full Text] [Related]
31. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
32. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study.
Keaney JF; Larson MG; Vasan RS; Wilson PW; Lipinska I; Corey D; Massaro JM; Sutherland P; Vita JA; Benjamin EJ;
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):434-9. PubMed ID: 12615693
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between insulin resistance and oxidative stress in vivo].
Hitsumoto T; Iizuka T; Takahashi M; Yoshinaga K; Matsumoto J; Shimizu K; Kaku M; Sugiyama Y; Sakurai T; Aoyagi K; Kanai M; Noike H; Ohsawa H; Watanabe H; Shirai K
J Cardiol; 2003 Sep; 42(3):119-27. PubMed ID: 14526661
[TBL] [Abstract][Full Text] [Related]
34. Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women.
Milewicz A; Jedrzejuk D; Dunajska K; Lwow F
Maturitas; 2010 Mar; 65(3):272-5. PubMed ID: 20004538
[TBL] [Abstract][Full Text] [Related]
35. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
Helmersson J; Vessby B; Larsson A; Basu S
Circulation; 2004 Apr; 109(14):1729-34. PubMed ID: 15037525
[TBL] [Abstract][Full Text] [Related]
36. Correlation between serum resistin level and adiposity in obese individuals.
Azuma K; Katsukawa F; Oguchi S; Murata M; Yamazaki H; Shimada A; Saruta T
Obes Res; 2003 Aug; 11(8):997-1001. PubMed ID: 12917505
[TBL] [Abstract][Full Text] [Related]
37. Sex steroid hormones, upper body obesity, and insulin resistance.
Abate N; Haffner SM; Garg A; Peshock RM; Grundy SM
J Clin Endocrinol Metab; 2002 Oct; 87(10):4522-7. PubMed ID: 12364429
[TBL] [Abstract][Full Text] [Related]
38. Relationship of obesity and body fat distribution with ceruloplasmin serum levels.
Cignarelli M; DePergola G; Picca G; Sciaraffia M; Pannacciulli N; Tarallo M; Laudadio E; Turrisi E; Giorgino R
Int J Obes Relat Metab Disord; 1996 Sep; 20(9):809-13. PubMed ID: 8880346
[TBL] [Abstract][Full Text] [Related]
39. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
40. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.
Vgontzas AN; Papanicolaou DA; Bixler EO; Hopper K; Lotsikas A; Lin HM; Kales A; Chrousos GP
J Clin Endocrinol Metab; 2000 Mar; 85(3):1151-8. PubMed ID: 10720054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
